Related Experiment Videos
Wolfram (DIDMOAD) syndrome
1Department of Growth and Endocrinology, The Children's Hospital, Ladywood, Birmingham, UK.
Journal of Medical Genetics
|November 14, 1997
Summary
Wolfram syndrome, a rare neurodegenerative disorder, links juvenile diabetes and optic atrophy. Early diagnosis and understanding its genetic basis are crucial for managing this progressive condition.
Area of Science:
- Genetics
- Neuroscience
- Endocrinology
Background:
- Wolfram syndrome, also known as DIDMOAD, is a rare autosomal recessive neurodegenerative disorder.
- Characterized by juvenile onset diabetes mellitus and optic atrophy, it progresses to include diabetes insipidus, deafness, and neurological abnormalities.
- The exact pathogenesis remains unknown, impacting patients with a prevalence of 1 in 770,000 in the UK.
Purpose of the Study:
- To summarize the clinical presentation, progression, and known genetic factors of Wolfram syndrome.
- To highlight the diagnostic challenges and differential diagnoses associated with this rare condition.
Main Methods:
- Review of existing literature on Wolfram syndrome.
- Analysis of clinical case reports and genetic studies.
Main Results:
- Wolfram syndrome presents with a distinct sequence of complications, including diabetes mellitus, optic atrophy, diabetes insipidus, sensorineural deafness, and neurological deficits.
- Genetic mapping has identified a Wolfram gene on chromosome 4p16.1, though locus heterogeneity and potential mitochondrial involvement are noted.
- Juvenile onset diabetes mellitus and optic atrophy are key diagnostic criteria, but a broad differential diagnosis is necessary.
Conclusions:
- Wolfram syndrome is a severe, progressive neurodegenerative disorder with a complex clinical phenotype.
- Further research into its pathogenesis and genetic underpinnings is essential for improved diagnostics and potential therapeutic strategies.